Memorial Sloan Kettering Cancer Center (MSK) clinical investigators recently produced study results published in the New England Journal of Medicine (NEJM), highlighting a promising new treatment for…
A trial site based in Illinois demonstrated recruitment competitive savvy, recently positioning publicly that they were the first such location to enroll patients for two…
An NYU Langone, Perlmutter Cancer Center researcher discovered that Amgen’s sotorasib reduced tumors in patients with non-small cell lung cancer (NSCLC) who also happened to…
Amgen, a leading global biotech company based in Southern California reported a first—the first time it has successfully achieved Breakthrough Therapy Designation (BTD) status by…
Yuhan Corp reports that it made three poster presentations at the virtual meeting of the American Society of Clinical Oncology (ASC) centering on the positive…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
